1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6FD11D0556098733B00258BBE0041145A
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-effective-oncology-hematologic-malignancies-medical-insights-management-team-structure-effectiveness-lessons-learned?opendocument
18
19opendocument
2018.97.14.85
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Effective Oncology (Hematologic Malignancies) Medical Insights Management: Team Structure, Effectiveness, and Lessons Learned

ID: 5851


Features:

21 Info Graphics

31 Data Graphics

370+ Metrics

15 Narratives


Pages/Slides: 64


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Effective Oncology (Hematologic Malignancies) Medical Insights Management: Team Structure, Effectiveness, and Lessons Learned”

STUDY OVERVIEW

The ability of Medical Affairs teams in Oncology, especially those focused on hematologic malignancies, to efficiently structure and disseminate insights can significantly improve treatment outcomes. However, it is crucial to identify the most effective models for ensuring critical insights reach key stakeholders at the right time.

Best Practices, LLC conducted this benchmarking study to uncover how top-performing organizations optimize their insight dissemination frameworks. This study provides a deep dive into the structural components that drive effectiveness, highlights real-world lessons learned from industry leaders, and offers actionable strategies to enhance the impact of Medical Affairs functions in hematologic oncology.

Benchmark data is broken down into two different segments to provide deeper insights. Classifications reflect their approach and standing in oncology (hematologic malignancies) medical insight generation: Insight Leaders (3 respondents) and Insight Majority (19 respondents).


KEY TOPICS

  • Structure of Oncology (Hematologic Malignancies) Medical Insights and Dissemination Group
  • Disseminating Oncology (Hematologic Malignancies) Insights: Tools, Activities and Effectiveness
  • Best Practices and Key Lessons Learned
  • Actionable Insights and Intelligence Gathering in Oncology (Hematologic Malignancies)

KEY METRICS

  • Presence of a separate group that gathers and disseminates oncology (hematologic malignancies) insights for Medical Affairs – Total benchmark class, Insight Leaders, and Insight Majority
  • Role of each of the groups within Medical Affairs for both gathering and disseminating oncology (hematologic malignancies) insights – Total benchmark class, Insight Leaders, and Insight Majority
  • Roles of Medical Affairs sub-functions in gathering and disseminating oncology (hematologic malignancies) insights – Insight Leaders and Insight Majority
  • Lead and support role of Medical Affairs groups in gathering and disseminating oncology (hematologic malignancies) insights – Total benchmark class
  • Level of expertise of the person who is responsible for conveying oncology (hematologic malignancies) medical insights to other functions – Total benchmark class, Insight Leaders, and Insight Majority
  • Strengths and weaknesses of oncology (hematologic malignancies) insights gathering and dissemination group structure
  • Breakdown of intelligence deliverables types in oncology (hematologic malignancies) – Total benchmark class, Insight Leaders, and Insight Majority
  • Tools used by Oncology (Hematologic Malignancies) Medical teams to deliver insights to other functions – Total benchmark class, Insight Leaders, and Insight Majority
  • Effectiveness and importance of digital tools used by the Oncology (Hematologic Malignancies) Medical Affairs team to gather, evaluate, and disseminate intelligence – Total benchmark class, Insight Leaders, and Insight Majority
  • Additional methods used by Oncology (Hematologic Malignancies) Medical Affairs teams to gather intelligence (beyond KOL and HCP engagement)

SAMPLE KEY FINDINGS

  • Insight Gathering Process and Its Effectiveness: Few conduct the Insight Process through a stand-alone group. Instead, they use various subfunctions to coordinate a slate of activities to ensure data is gathered and input into a system. They may choose to coordinate work across other inter-functional groups, often with limited success.

METHODOLOGY

Best Practices, LLC partnered with 22 executives from 17 top life sciences companies specializing in oncology (hematologic malignancies) to uncover critical benchmarking insights. The study insights are mostly from directors and higher management executives, representing nearly 80% of the benchmark participants.

Industries Profiled:
Pharmaceutical; Communications; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Chemical


Companies Profiled:
Agios; ApotheCom; Bayer; Boehringer Ingelheim; Eli Lilly and Company; Daiichi Sankyo; Eisai; Genentech; Janssen; Merck; Novartis; Roche; Sanofi Genzyme; Sandoz; Servier; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.